Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Carcinogenesis|March 19, 2005
LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in ChinaBangwei Cao, Xiuyun Tian, Yong Li, et al.
Complementary Therapies in Medicine|February 11, 2016
Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patientsYan Han, Huan Wang, Weiru Xu, et al.
Frontiers in Oncology|May 30, 2023
Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detectionZhibin Chen, Jie Xing, Cuiling Zheng, et al.
Frontiers in Oncology|August 15, 2020
Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced AdenomaHejing Wang, Bei Zhang, Xiaojin Li, et al.
Med (New York, N.Y.)|June 13, 2024
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trialZi-Xian Wang, Junjie Peng, Xinjun Liang, et al.
Ebiomedicine|July 3, 2015
An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular CarcinomaYu Hong, Jiang Long, Hai Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 23, 2016
[A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]Binghe Xu, Fuguo Tian, Jingrui Yu, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2021
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialShukui Qin, Qiu Li, Shanzhi Gu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2021
Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphomaDan Liu, Chunguang Ma, Ping Lu, et al.
Translational Lung Cancer Research|February 4, 2020
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancerYunpeng Yang, Bin Wu, Linian Huang, et al.
Pageof 11